Imbed Biosciences

01/29/2026

Having an incredible week at the 𝟐𝟎𝟐𝟔 𝐉𝐨𝐡𝐧 𝐀. 𝐁𝐨𝐬𝐰𝐢𝐜𝐤 𝐁𝐮𝐫𝐧 & 𝐖𝐨𝐮𝐧𝐝 𝐒𝐲𝐦𝐩𝐨𝐬𝐢𝐮𝐦, and we’d like to spotlight some truly outstanding clinicians:

▸𝐃𝐫. 𝐌𝐢𝐜𝐡𝐚𝐞𝐥 𝐒𝐜𝐡𝐮𝐫𝐫 shared powerful work using 𝐏𝐞𝐥𝐚𝐬𝐡𝐢𝐞𝐥𝐝™ over epidermal autograft to 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐠𝐫𝐚𝐟𝐭 𝐭𝐚𝐤𝐞 and burn closure.
▸𝐃𝐫. 𝐂𝐚𝐫𝐦𝐞𝐧 𝐅𝐥𝐨𝐫𝐞𝐬 talked about 𝐢𝐦𝐩𝐫𝐨𝐯𝐞𝐝 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬 in burns and necrotizing infections using 𝐏𝐞𝐥𝐚𝐬𝐡𝐢𝐞𝐥𝐝™, plus how well it 𝐩𝐚𝐢𝐫𝐬 𝐰𝐢𝐭𝐡 𝐜𝐨𝐦𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐚𝐫𝐲 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬.
▸𝐃𝐫. 𝐌𝐚𝐫𝐤 𝐆𝐫𝐚𝐧𝐢𝐜𝐤 presented a new two stage reconstructive approach for 𝐡𝐢𝐝𝐫𝐚𝐝𝐞𝐧𝐢𝐭𝐢𝐬 𝐬𝐮𝐩𝐩𝐮𝐫𝐚𝐭𝐢𝐯𝐚 wounds, calling it “effective, reproducible, and less morbid” when incorporating 𝐏𝐞𝐥𝐚𝐬𝐡𝐢𝐞𝐥𝐝™ for 𝐰𝐨𝐮𝐧𝐝 𝐛𝐞𝐝 𝐩𝐫𝐞𝐩𝐚𝐫𝐚𝐭𝐢𝐨𝐧 prior to autographing.

Not pictured but equally impressive: 𝐃𝐫. 𝐓𝐡𝐞𝐚 𝐏𝐫𝐢𝐜𝐞, who shared case work using 𝐏𝐞𝐥𝐚𝐬𝐡𝐢𝐞𝐥𝐝™ 𝐏𝐚𝐢𝐧𝐆𝐮𝐚𝐫𝐝™, noting both its structural coverage and meaningful early analgesic benefit.

Always a pleasure to learn from their incredible research and engage with leaders pushing burn and wound care forward.

01/27/2026

Thrilled to be back at Boswick, surrounded by the leaders shaping the future of burn care.
Be sure to connect with Terry Bromley, Dr. Michael Schurr, Brad Wiggins, and Dave Posten—and ask about the four new studies being presented that showcase Pelashield™ and Pelashield™ with PainGuard™.

01/22/2026

After a serious motorcycle accident, recovery can be a long and uncertain road.

John Ewell, a 74-year-old motorcycle accident survivor, sustained extensive injuries to his left side after sliding approximately 60 feet while avoiding a collision, with wounds comparable to second-degree burns.
As part of his wound care journey, Imbed Biosciences’ SAM™ Antimicrobial Technology was used, and John began to see noticeable improvement within the first week. Over time, his wounds continued to heal, with only minimal scarring observed at nine months.

Stories like John’s remind us why patient-centered innovation matters — and why listening to real experiences is so important in wound care.

👉 Watch John’s full story:
https://hubs.li/Q03_XF530

01/09/2026

𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐧𝐠 𝐈𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐧 𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐢𝐧 𝐎𝐫𝐭𝐡𝐨𝐩𝐞𝐝𝐢𝐜 𝐒𝐮𝐫𝐠𝐞𝐫𝐲

Dr. 𝐒𝐞𝐚𝐧 𝐆𝐫𝐢𝐟𝐟𝐢𝐧, Orthopedic Surgeon at Ellis & Badenhausen Orthopaedics (Louisville, KY), recently shared his experience using 𝐈𝐦𝐛𝐞𝐝’𝐬 𝐒𝐮𝐫𝐠𝐚𝐟𝐥𝐞𝐱™ during a total hip replacement on a high-risk patient at 𝐍𝐨𝐫𝐭𝐨𝐧 𝐖𝐨𝐦𝐞𝐧’𝐬 & 𝐂𝐡𝐢𝐥𝐝𝐫𝐞𝐧’𝐬 𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥.

His perspective? This long-sought solution delivers:
✅ 𝐇𝐢𝐠𝐡 𝐞𝐟𝐟𝐢𝐜𝐚𝐜𝐲 in reducing surgical site infection (SSI) risk
✅ 𝐄𝐚𝐬𝐞 𝐨𝐟 𝐮𝐬𝐞 for surgical teams
✅ 𝐍𝐨 𝐬𝐢𝐝𝐞 𝐞𝐟𝐟𝐞𝐜𝐭𝐬 for patients
✅ 𝐂𝐨𝐬𝐭-𝐞𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞𝐧𝐞𝐬𝐬 for healthcare systems

Surgaflex™ is helping surgeons confidently manage infection risk in compromised patient populations—driving toward our collective goal of 𝐆𝐞𝐭𝐭𝐢𝐧𝐠 𝐭𝐨 𝐙𝐞𝐫𝐨
SSIs.

01/07/2026

We’re heading to the 48th Annual John A. Boswick Burn & Wound Symposium this month 🌴

This international conference brings together physicians, nurses, researchers, and medical specialists to explore the latest advancements in wound healing, burn care, and infection control and we’re looking forward to being part of the conversation.

📍 Visit us at Boswick 2026 to learn more about Imbed Biosciences and how we’re supporting advances in wound healing, burn care, and infection control.

01/01/2026

𝐇𝐚𝐩𝐩𝐲 𝐍𝐞𝐰 𝐘𝐞𝐚𝐫!

Thank you to our incredible partners and team for driving innovation forward. Here’s to building even more together in 2026!

12/31/2025

As we count down to 2026, we’re grateful for the progress made, the partnerships built, and the work done to support surgeons and the patients they care for.

We’re excited for what’s ahead and ready to build on that momentum in the year to come.

12/23/2025

Wishing you a happy holiday season from all of us at Imbed Biosciences.

Thank you to our partners, clinicians, and colleagues for your continued collaboration and support.

12/21/2025

Unlock Better Tissue Regeneration Outcomes!
Watch Imbed’s on-demand webinar https://hmp-global.swoogo.com/sam-antimicrobial-technology-and-a-new-solution-to-help-manage-both-infection-risk-and-pain featuring real-world case studies with SAM™ Antimicrobial Technology.

👩‍⚕️ Experts:
• Dr. Suhail Sharif, MD – Surgical Oncologist (featured in clip)
• Dr. Damien Dauphinée, DPM – Podiatric Surgeon
• Dr. Gaurav Pranami, PhD – VP of R&D, Imbed Biosciences

✅ Burn care & surgical insights
✅ Managing infection risk and pain
✅ Using SAM™ core + PainGuard™ matrix to support healing outcomes

Together, let’s reach for the “Zero Zone”—zero infection, zero pain, zero graft loss, zero delays.

12/17/2025

𝐑𝐞𝐝𝐮𝐜𝐢𝐧𝐠 𝐩𝐚𝐢𝐧 𝐢𝐬𝐧’𝐭 𝐣𝐮𝐬𝐭 𝐚𝐛𝐨𝐮𝐭 𝐜𝐨𝐦𝐟𝐨𝐫𝐭—𝐢𝐭’𝐬 𝐚𝐛𝐨𝐮𝐭 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬 𝐚𝐧𝐝 𝐞𝐜𝐨𝐧𝐨𝐦𝐢𝐜𝐬.

Better post-procedure pain control can help reduce billions in avoidable readmission costs, while improving recovery and quality of life for patients.

𝐒𝐀𝐌™ 𝐀𝐧𝐭𝐢𝐦𝐢𝐜𝐫𝐨𝐛𝐢𝐚𝐥 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐰𝐢𝐭𝐡 𝐏𝐚𝐢𝐧𝐆𝐮𝐚𝐫𝐝™
✔ Supports tissue regeneration
✔ Reduces infection risk
✔ Minimizes PAIN

Innovation that matters—for patients and for healthcare systems.

11/26/2025

11/25/2025

Imbed Biosciences is helping clinicians address both 𝐢𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐧 𝐫𝐢𝐬𝐤 and 𝐩𝐚𝐢𝐧 𝐦𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 with advanced solutions powered by 𝐒𝐀𝐌™ 𝐀𝐧𝐭𝐢𝐦𝐢𝐜𝐫𝐨𝐛𝐢𝐚𝐥 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲.
Because when it comes to infections, 𝐳𝐞𝐫𝐨 𝐢𝐬 𝐭𝐡𝐞 𝐠𝐨𝐚𝐥.